Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jessica McCarty"'
Autor:
Harjeet Singh, Samer A. Srour, Denái R. Milton, Jessica McCarty, Cuiping Dai, Mahmoud R. Gaballa, Mariam Ammari, Simon Olivares, Helen Huls, Eleanor De Groot, David Marin, Demetrios Petropoulos, Amanda L. Olson, Paolo Anderlini, Jin S. Im, Issa Khouri, Chitra M. Hosing, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Laurence J. N. Cooper, Partow Kebriaei
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T-cell therapy has emerged recently as a standard of care treatment for patients with relapsed or refractory acute lymphoblastic leukemia (ALL) and several subtypes of B-cell non-Hodgkin lymphoma (NHL). However, its us
Externí odkaz:
https://doaj.org/article/9569f80e06114c10ac15c8046aef34f8
Autor:
Pavel Groisman, Herman Shugart, David Kicklighter, Geoffrey Henebry, Nadezhda Tchebakova, Shamil Maksyutov, Erwan Monier, Garik Gutman, Sergey Gulev, Jiaguo Qi, Alexander Prishchepov, Elena Kukavskaya, Boris Porfiriev, Alexander Shiklomanov, Tatiana Loboda, Nikolay Shiklomanov, Son Nghiem, Kathleen Bergen, Jana Albrechtová, Jiquan Chen, Maria Shahgedanova, Anatoly Shvidenko, Nina Speranskaya, Amber Soja, Kirsten de Beurs, Olga Bulygina, Jessica McCarty, Qianlai Zhuang, Olga Zolina
Publikováno v:
Progress in Earth and Planetary Science, Vol 4, Iss 1, Pp 1-48 (2017)
Abstract During the past several decades, the Earth system has changed significantly, especially across Northern Eurasia. Changes in the socio-economic conditions of the larger countries in the region have also resulted in a variety of regional envir
Externí odkaz:
https://doaj.org/article/4158b32b838e46dab7c473d03e7f6b78
Publikováno v:
Remote Sensing, Vol 11, Iss 2, p 104 (2019)
Mount Kenya is one of Kenya’s ‘water towers’, the headwaters for the country’s major rivers including the Tana River and Ewaso Nyiro River, which provide water and hydroelectric power to the semiarid region. Fires affect water downstream, but
Externí odkaz:
https://doaj.org/article/fb957ce793304108834a64fd07cf49c2
Autor:
Helen Huls, G. Bardelli, J. Buck, E. de Groot, Partow Kebriaei, Amin M. Alousi, Samer A. Srour, Chitra Hosing, David Marin, William G. Wierda, Harjeet Singh, Y. Nieto, Hagop M. Kantarjian, Jessica McCarty, Laurence J.N. Cooper, U. Popat, Elizabeth J. Shpall, Richard E. Champlin, Stefan O. Ciurea, Gabriella Rondon, Katy Rezvani, M.H. Qazilbash
Publikováno v:
Blood
Autor:
Harold N. Keer, Chitra Hosing, Gheath Alatrash, Betul Oran, Rohtesh S. Mehta, Jessica McCarty, Amin M. Alousi, Jin S. Im, Richard E. Champlin, Jennifer D Ramos, Peter F. Thall, Uday R. Popat
Publikováno v:
Blood. 136:29-30
Background: Disease relapse remains to be the one of the major reasons of treatment failures after allogeneic stem cell transplantation (allo-SCT) in AML and MDS patients (pts). SGI-110 is a next generation hypomethylating agent that molecularly is a
Autor:
Harold N. Keer, David Marin, Partow Kebriaei, Jessica McCarty, Peter F. Thall, Amin M. Alousi, Uday R. Popat, Rohtesh S. Mehta, Jennifer D Ramos, Amanda Olson, Betul Oran, Richard E. Champlin, Roland L. Bassett
Publikováno v:
Blood. 136:10-11
Background: Disease relapse remains to be the one of the major reasons of treatment failures after allogeneic stem cell transplantation (allow-SCT) in AML and MDS patients (pts.). Guadecitabineis (SGI-110) a next generation hypomethylating agent that
Autor:
Katy Rezvani, Richard E. Champlin, Yago Nieto, Catherine Sobieiski, Sairah Ahmed, Enli Liu, Chitra Hosing, Qaiser Bashir, Catherine M. Bollard, Nina Shah, Robert Z. Orlowski, Eric Yvon, Hila Shaim, Krina K. Patel, Muharrem Muftuoglu, Kai Cao, Li Li, Simrit Parmar, Muzaffar H. Qazilbash, Jessica McCarty, Rima M. Saliba, Indreshpal Kaur, Elizabeth J. Shpall, Laurence J.N. Cooper, Dean A. Lee
Publikováno v:
British journal of haematology, vol 177, iss 3
Multiple myeloma (MM) is a disease with known immune dysregulation. Natural killer (NK) cells have shown preclinical activity in MM. We conducted a first-in-human study of umbilical cord blood-derived (CB) NK cells for MM patients undergoing high dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818308f48cf3676007ae10b3437bfd66
https://escholarship.org/uc/item/8pg029rf
https://escholarship.org/uc/item/8pg029rf
Autor:
Sairah Ahmed, David Marin, Richard E. Champlin, Qaiser Bashir, Partow Kebriaei, Yago Nieto, Uday R. Popat, Trishala Agrawal, Betul Oran, Jessica McCarty, Amanda Olson, Stefan O. Ciurea, Elizabeth J. Shpall
Publikováno v:
Blood. 132:3426-3426
Background: FLT3 inhibitors (like sorafenib and midostaurin) have been administered as maintenance therapy post allogeneic stem cell transplantation (SCT) to reduce persistent relapse risks in FLT3-mutant AML patients. Reduced doses of both sorafenib